The urinary biomarker combination [TIMP-2] × [IGFBP7], which are both markers for G1 cell cycle arrest, has been identified and validated to predict moderate to severe acute kidney injury in critically ill patients earlier than other known biomarkers [10]. This evidence concerns the gene IGFBP7 and acute kidney injury.